Scisparc : Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption – Form 6-K
Pre-clinical trials based on the proprietary combination demonstratesignificant suppressive effect on alcohol consumption TEL AVIV, Israel, May 24, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical […]